Outcome Research in Bowel Irrigation Techniques for the Treatment of Chronic Constipation and/or Faecal Incontinence

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorQufora A/S

About this trial

This clinical investigation is a post-market, exploratory, randomised, parallel, open-label investigation comparing two UKCA/CE-marked transanal irrigation products for the management of faecal incontinence and/or chronic constipation of heterogenous origin. The aim of this investigation is to assess outcomes in a real-world clinical setting, by following the typical clinical routine, with randomisation and more frequent visits/phone calls as the only difference from typical clinical procedure.

During 4-week training period, participants will trained by nurse specialists on how to use the device to which they were randomised to and will be instructed to irrigate once per day. For the remainder of the investigation, participants will be advised to continue irrigation once daily (or a minimum of 3 times a week). Participants will be followed up via phone call or in-person visit up to 52 weeks.

Eligibility criteria

Qualifiers

Faecal incontinence (FI), chronic constipation (CC) or co-existing FI/CC, all of heterogenous origin

Positive Rome IV criteria for functional constipation and/or positive Rome IV criteria for faecal incontinence

18 years or older

Ability to understand written and spoken English (due to questionnaire validity)

Disqualifiers

Prior use of transanal irrigation

Neurogenic bowel dysfunction

Low anterior resection syndrome (this group will be excluded due to the possibility of being randomised to a balloon catheter).

Previous rectal and/or anal surgery (except minor rectal or anal surgery such as haemorrhoid procedures, anal fissure surgery, drainage of a perianal/rectal abscess, or other rectal or anal surgeries deemed minor by the investigator)

Trial design

Treatments tested in this trial

  • Transanal irrigation

Treatment groups

66 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators